CTLA4 and cancer: Immune checkpoint blockade (ICB) targeting T cell inhibitory receptors: cytotoxic T lymphocyte associated protein-4 (CTLA-4) and programmed cell death protein-1/ligand-1 (PD-1/PD-L1) have revolutionized cancer treatment.